 |
|
|
| |
All-Oral Therapy With Sofosbuvir Plus Ribavirin For the Treatment of HCV Genotype 1, 2, and 3 Infection in Patients Co-infected With HIV (PHOTON-1)
|
| |
| |
Reported by Jules Levin
AASLD 2013 Nov 1-4 Wash DC
Mark Sulkowski1, Maribel Rodriguez-Torres2, Jacob Lalezari3,
W. Jeffrey Fessel4, Karam Mounzer5, Margaret Shuhart6, Annie Luetkemeyer7, David Asmuth8, Anuj Gaggar9, Liyun Ni9, Evguenia Svarovskaia9, Bill Symonds9, John McHutchison9, Susanna Naggie10, Douglas Dieterich11
1Johns Hopkins University, Baltimore, MD; 2Fundacion De Investigacion San Juan, PR; 3Quest Clinical Research, San Francisco, CA; 4Kaiser Permanente, San Francisco, CA; 5Philadelphia FIGHT, Philadelphia, PA; 6Harborview Medical Center, University of Washington, Seattle, WA;
7San Francisco General Hospital, University of California, San Francisco, CA; 8University of California Davis Medical Center in Sacramento, CA; 9Gilead Sciences, Foster City, CA; 10Duke Clinical Research Institute, Durham, NC; 11Mount Sinai School of Medicine, New York, NY
|
| |
|
|
|
|
|
